THE INNOVATIVE MEDICINES INITIATIVE

The Innovative Medicines Initiative (IMI) is Europe's largest public-private initiative aiming to speed up the development of better and safer medicines for patients.

IMI supports collaborative research projects and builds networks of industrial and academic experts in order to boost pharmaceutical innovation in Europe.

IMI is a joint undertaking between the European Union and the pharmaceutical industry association EFPIA.

EU Logoefpia Logo

 

Introducing the new IMI logo

The launch of the IMI 2 programme marks the beginning of a new and exciting chapter in the IMI story, and it is in this spirit that we decided the time had come to freshen up the IMI logo and our broader corporate identity.

more

ONGOING PROJECTS

  • A life-saving technology

    IMI project SUMMIT has developed an ultrasound device to identify patients at imminent risk of a heart attack or stroke

    ... more
  • Action on autism

    Watch a video on how EU-AIMS is developing tools to boost our understanding of autism, paving the way for new treatments

    ... more
  • Get on-course!

    With over 5 000 courses, on-course, run by the EMTRAIN project, is Europe's most comprehensive biomedical R&D postgrad course portal

    ... more
  • Innovation in action

    IMI's 46 projects have a combined budget of €1.6 billion and are tackling some of the toughest challenges in drug development.

    ... more
  • Patient power!

    EUPATI is developing educational resources that will empower patients to engage more effectively in the drug research and development process

    ... more
  • Schizophrenia breakthrough

    NEWMEDS project research published in Nature reveals that genetic variants linked with schizophrenia have an impact in healthy carriers

    ... more
All projects

IMI 2 - CALL 2

The following topics are under consideration for inclusion in IMI 2 -Call 2:

 - Remote assessment
 - Type 2 diabetes
 - Neuropsychiatry
 - Vaccine manufacture
 - Pertussis vaccines
 - Patient engagement
 - Adaptive pathways

IMI NEWSFLASH IMI News Flash

 
  • 31/10/2014 : RT @eupatients: Any more great collaborative ideas between patients and other stakeholders? Tell us about it! #eupati2104 http://t.co/2kGrs
  • 31/10/2014 : RT @troosters: several @PROactiveCOPD investigators contribute to a statement on 'Physical activity in COPD' of @ERSTalk. http://t.co/FmDW
  • 30/10/2014 : RT @PROTECT_BR: How to communicate #BenefitRisk of #obesity interventions for weight loss in the #obese? http://t.co/jQxJp68WMP http://t.co

Follow us on Twitter